Advanced Nanotherapies (Ant) Secures $4M Strategic Investment To Accelerate Clinical Development Of Sirplux Duo Drug-Coated Balloon (Dcb) For Treating De Novo Coronary Artery Disease (Cad)
Amount Raised
$4 Million
Round Type
Seed
Los GatosManufacturingBiotechnologyHealth CareScience And EngineeringInvestors
Description
Advanced NanoTherapies Inc. (ANT), a clinical-stage medical device company committed to solving the most significant challenges in vascular disease through the creative applications of nanotechnology, today announced a $4M Series A extension from a prominent undisclosed strategic medical device company. Additionally, ANT successfully treated the first cohort of study participants in its ADVANCE-DCB first-in-human (FIH) trial, demonstrating initial short-term safety data for the next-generation SirPlux Duo Drug-Coated Balloon (DCB). The trial is evaluating the safety and performance of the SirPlux Duo DCB in de novo coronary artery disease (CAD).
Quick answer
Advanced NanoTherapies raised $4 Million in a Seed round, dated August 22, 2023. Investors: Ant. Advanced NanoTherapies is based in Los Gatos, California, United States.
- How much did Advanced NanoTherapies raise?
- Advanced NanoTherapies raised $4 Million in a Seed round on August 22, 2023.
- Who invested in Advanced NanoTherapies?
- Ant is named as investors in this round.
- What does Advanced NanoTherapies do?
- AdvNanoT is based on biodegradable nanoparticles (NP) specifically designed to have higher vascular uptake and cellular retention.
- Where is Advanced NanoTherapies based and how big is it?
- Advanced NanoTherapies is based in Los Gatos, California, United States. Fundz records about 17 employees.
- Who are the decision-makers at Advanced NanoTherapies?
- Fundz holds 1 contact at Advanced NanoTherapies. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Science And Engineering and Manufacturing around the same time
Companies in the same sectors as Advanced NanoTherapies that raised within 45 days of this round, from Fundz verified event records.
- RedHill Biopharma Ltd raised $4M (Seed) on September 28, 2023.
- RedHill Biopharma Ltd raised $2.7M (Seed) on July 21, 2023.
- Experic raised an undisclosed amount (Series B) on October 5, 2023.
- Endovia Health Sciences, Inc. raised $1.3M (Seed) on October 5, 2023.
- Aurora Cannabis raised $31M (Funding Round) on October 3, 2023.
- Deka Biosciences, Inc. raised $20M (Series B) on September 28, 2023.
Who to call at Advanced NanoTherapies, and when
A new round usually means Advanced NanoTherapies is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Advanced NanoTherapies raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Advanced NanoTherapies, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Advanced NanoTherapies. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Advanced NanoTherapies raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Advanced NanoTherapies raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.